(CercleFinance.com) – Lysogene announced on Friday that it was looking for a buyer or an investor with the formalization of the opening of receivership proceedings.
The biopharmaceutical company, specializing in gene therapies, indicates that it has requested, with its receiver, the conversion of the safeguard procedure which it has been subject to since last December into receivership proceedings.
The Commercial Court of Nanterre must rule on his request in the coming days.
The company justifies this decision by the fact that the safeguard procedure did not make it possible to identify a solution to consolidate its financial situation, nor to perpetuate its financing horizon.
In this context, a call for tenders for the purpose of finding buyers or investors has been published, the deadline for submitting takeover bids having been set for 15 February.
In the meantime, its share price remains suspended on the Paris Stock Exchange.